25 related articles for article (PubMed ID: 31351087)
1. Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells.
Laudisi F; Cherubini F; Di Grazia A; Dinallo V; Di Fusco D; Franzè E; Ortenzi A; Salvatori I; Scaricamazza S; Monteleone I; Sakamoto N; Monteleone G; Stolfi C
Mol Oncol; 2019 Oct; 13(10):2142-2159. PubMed ID: 31361391
[TBL] [Abstract][Full Text] [Related]
2. Anthelmintic Drugs as Emerging Immune Modulators in Cancer.
Stolfi C; Pacifico T; Luiz-Ferreira A; Monteleone G; Laudisi F
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047419
[TBL] [Abstract][Full Text] [Related]
3. Salicylanilides and Their Anticancer Properties.
Kauerová T; Pérez-Pérez MJ; Kollar P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675241
[TBL] [Abstract][Full Text] [Related]
4. Discovery of rafoxanide as a novel agent for the treatment of non-small cell lung cancer.
Hu A; Liu J; Wang Y; Zhang M; Guo Y; Qin Y; Liu T; Men Y; Chen Q; Liu T
Sci Rep; 2023 Jan; 13(1):693. PubMed ID: 36639421
[TBL] [Abstract][Full Text] [Related]
5. Differences in the characteristics and pulmonary toxicity of nano- and micron-sized respirable coal dust.
Zhang Y; Li A; Gao J; Liang J; Cao N; Zhou S; Tang X
Respir Res; 2022 Jul; 23(1):197. PubMed ID: 35906696
[TBL] [Abstract][Full Text] [Related]
6. Double Repositioning: Veterinary Antiparasitic to Human Anticancer.
Sultana T; Jan U; Lee JI
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457127
[TBL] [Abstract][Full Text] [Related]
7. Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.
Moghadam ER; Ang HL; Asnaf SE; Zabolian A; Saleki H; Yavari M; Esmaeili H; Zarrabi A; Ashrafizadeh M; Kumar AP
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32992587
[TBL] [Abstract][Full Text] [Related]
8. Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System.
Laudisi F; Marônek M; Di Grazia A; Monteleone G; Stolfi C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668817
[TBL] [Abstract][Full Text] [Related]
9. Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.
Shi X; Li H; Shi A; Yao H; Ke K; Dong C; Zhu Y; Qin Y; Ding Y; He YH; Liu X; Li L; Lei L; Hai Q; Chen W; Leung KS; Wong MH; Kung HF; Lin MC
Oncol Rep; 2018 Sep; 40(3):1592-1600. PubMed ID: 29956794
[TBL] [Abstract][Full Text] [Related]
10. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing.
El Zarif T; Yibirin M; De Oliveira-Gomes D; Machaalani M; Nawfal R; Bittar G; Bahmad HF; Bitar N
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565237
[TBL] [Abstract][Full Text] [Related]
11. Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide.
Laudisi F; Di Grazia A; De Simone V; Cherubini F; Colantoni A; Ortenzi A; Franzè E; Dinallo V; Di Fusco D; Monteleone I; Fearon ER; Monteleone G; Stolfi C
Cancer Lett; 2019 Oct; 462():1-11. PubMed ID: 31351087
[TBL] [Abstract][Full Text] [Related]
12. Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis.
Laudisi F; Pacifico T; Maresca C; Luiz-Ferreira A; Antonelli S; Ortenzi A; Colantoni A; Di Grazia A; Franzè E; Colella M; Di Fusco D; Sica GS; Monteleone I; Monteleone G; Stolfi C
Biomed Pharmacother; 2022 Nov; 155():113794. PubMed ID: 36271571
[TBL] [Abstract][Full Text] [Related]
13. Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells.
Di Grazia A; Laudisi F; Di Fusco D; Franzè E; Ortenzi A; Monteleone I; Monteleone G; Stolfi C
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455811
[TBL] [Abstract][Full Text] [Related]
14. Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.
Xiao W; Xu Z; Chang S; Li B; Yu D; Wu H; Xie Y; Wang Y; Xie B; Sun X; Kong Y; Lan X; Bu W; Chen G; Gao L; Wu X; Shi J; Zhu W
Cancer Lett; 2019 Mar; 444():45-59. PubMed ID: 30583070
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
